Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U.

J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357. Epub 2014 Jan 13. Erratum in: J Clin Oncol. 2014 May 10;32(14):1520.

PMID:
24419137
[PubMed - indexed for MEDLINE]
2.

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3713-8. doi: 10.1073/pnas.1100048108. Epub 2011 Feb 7.

PMID:
21300873
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.

Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C.

Eur J Cancer Prev. 2012 May;21(3):308-15. doi: 10.1097/CEJ.0b013e328351e1b6.

PMID:
22465911
[PubMed - indexed for MEDLINE]
4.

Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Aberle DR, Abtin F, Brown K.

J Clin Oncol. 2013 Mar 10;31(8):1002-8. doi: 10.1200/JCO.2012.43.3110. Epub 2013 Feb 11. Review.

PMID:
23401434
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team.

JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. Erratum in: JAMA Intern Med. 2014 May;174(5):828.

PMID:
24322569
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effective use of low-dose computed tomography lung cancer screening.

Jeffers CD, Pandey T, Jambhekar K, Meek M.

Curr Probl Diagn Radiol. 2013 Sep-Oct;42(5):220-30. doi: 10.1067/j.cpradiol.2013.05.001. Review.

PMID:
24070715
[PubMed - indexed for MEDLINE]
7.

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG.

Ann Intern Med. 2013 Sep 17;159(6):411-20. doi: 10.7326/0003-4819-159-6-201309170-00690. Review.

PMID:
23897166
[PubMed - indexed for MEDLINE]
8.

Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.

Rzyman W, Jelitto-Gorska M, Dziedzic R, Biadacz I, Ksiazek J, Chwirot P, Marjanski T.

Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):969-73. doi: 10.1093/icvts/ivt388. Epub 2013 Sep 5.

PMID:
24008181
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group.

Lung Cancer. 2007 Oct;58(1):50-8. Epub 2007 Jul 12.

PMID:
17624475
[PubMed - indexed for MEDLINE]
10.

Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.

Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS.

Ann Intern Med. 2010 Apr 20;152(8):505-12, W176-80. doi: 10.7326/0003-4819-152-8-201004200-00007. Erratum in: Ann Intern Med. 2010 Jun 1;152(11):759.

PMID:
20404381
[PubMed - indexed for MEDLINE]
11.

A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.

Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G; DANTE Study Group.

Am J Respir Crit Care Med. 2009 Sep 1;180(5):445-53. doi: 10.1164/rccm.200901-0076OC. Epub 2009 Jun 11.

PMID:
19520905
[PubMed - indexed for MEDLINE]
12.

Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.

Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group.

Chest. 2004 Jul;126(1):114-21.

PMID:
15249451
[PubMed - indexed for MEDLINE]
13.

The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.

Kagna O, Solomonov A, Keidar Z, Bar-Shalom R, Fruchter O, Yigla M, Israel O, Guralnik L.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):997-1004. doi: 10.1007/s00259-009-1061-9. Epub 2009 Feb 5.

PMID:
19194704
[PubMed - indexed for MEDLINE]
14.

Benefits and harms of CT screening for lung cancer: a systematic review.

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.

JAMA. 2012 Jun 13;307(22):2418-29. doi: 10.1001/jama.2012.5521. Review. Erratum in: JAMA. 2013 Jun 5;309(21):2212. JAMA. 2012 Oct 3;308(13):1324.

PMID:
22610500
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

ROC curves for low-dose CT in the National Lung Screening Trial.

Pinsky PF, Gierada DS, Nath H, Kazerooni EA, Amorosa J.

J Med Screen. 2013;20(3):165-8. doi: 10.1177/0969141313500666. Epub 2013 Aug 30.

PMID:
24009092
[PubMed - indexed for MEDLINE]
16.

Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials.

Gopal M, Abdullah SE, Grady JJ, Goodwin JS.

J Thorac Oncol. 2010 Aug;5(8):1233-9. doi: 10.1097/JTO.0b013e3181e0b977.

PMID:
20548246
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.

Pinsky PF, Church TR, Izmirlian G, Kramer BS.

Cancer. 2013 Nov 15;119(22):3976-83. doi: 10.1002/cncr.28326. Epub 2013 Aug 26.

PMID:
24037918
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations.

Callol L, Roig F, Cuevas A, de Granda JI, Villegas F, Jareño J, Arias E, Albiach JM.

Lung Cancer. 2007 May;56(2):217-21. Epub 2007 Feb 20.

PMID:
17316889
[PubMed - indexed for MEDLINE]
19.

Biomarkers to the rescue in a lung nodule epidemic.

Massion PP.

J Clin Oncol. 2014 Mar 10;32(8):725-6. doi: 10.1200/JCO.2013.54.0047. Epub 2014 Feb 10. No abstract available.

PMID:
24516023
[PubMed - indexed for MEDLINE]
20.

Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation [Internet].

Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore C.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jul.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk